378 related articles for article (PubMed ID: 19328609)
1. "It's all the time in my mind": facilitators of adherence to antiretroviral therapy in a Tanzanian setting.
Watt MH; Maman S; Earp JA; Eng E; Setel PW; Golin CE; Jacobson M
Soc Sci Med; 2009 May; 68(10):1793-800. PubMed ID: 19328609
[TBL] [Abstract][Full Text] [Related]
2. Barriers and facilitators of adherence to antiretroviral drug therapy and retention in care among adult HIV-positive patients: a qualitative study from Ethiopia.
Bezabhe WM; Chalmers L; Bereznicki LR; Peterson GM; Bimirew MA; Kassie DM
PLoS One; 2014; 9(5):e97353. PubMed ID: 24828585
[TBL] [Abstract][Full Text] [Related]
3. Barriers to HIV Treatment Adherence: A Qualitative Study of Discrepancies Between Perceptions of Patients and Health Providers in Tanzania and Uganda.
Moucheraud C; Stern AF; Ahearn C; Ismail A; Nsubuga-Nyombi T; Ngonyani MM; Mvungi J; Ssensamba J
AIDS Patient Care STDS; 2019 Sep; 33(9):406-413. PubMed ID: 31517526
[TBL] [Abstract][Full Text] [Related]
4. Barriers and Facilitators for Antiretroviral Treatment Adherence Among HIV-Positive African American and Latino Men Who Have Sex With Men.
Carey JW; Carnes N; Schoua-Glusberg A; Kenward K; Gelaude D; Denson DJ; Gall E; Randall LA; Frew PM
AIDS Educ Prev; 2019 Aug; 31(4):306-324. PubMed ID: 31361514
[TBL] [Abstract][Full Text] [Related]
5. Barriers and facilitators to patients' adherence to antiretroviral treatment in Zambia: a qualitative study.
Sanjobo N; Frich JC; Fretheim A
SAHARA J; 2008 Sep; 5(3):136-43. PubMed ID: 18979047
[TBL] [Abstract][Full Text] [Related]
6. Antiretroviral therapy initiation and adherence in rural South Africa: community health workers' perspectives on barriers and facilitators.
Loeliger KB; Niccolai LM; Mtungwa LN; Moll A; Shenoi SV
AIDS Care; 2016 Aug; 28(8):982-93. PubMed ID: 27043077
[TBL] [Abstract][Full Text] [Related]
7. Determinants of antiretroviral therapy adherence in northern Tanzania: a comprehensive picture from the patient perspective.
Lyimo RA; de Bruin M; van den Boogaard J; Hospers HJ; van der Ven A; Mushi D
BMC Public Health; 2012 Aug; 12():716. PubMed ID: 22935331
[TBL] [Abstract][Full Text] [Related]
8. Facilitators and barriers to antiretroviral therapy adherence among HIV-positive adolescents living in Tanzania.
Audi C; Jahanpour O; Antelman G; Guay L; Rutaihwa M; van de Ven R; Woelk G; Baird SJ
BMC Public Health; 2021 Dec; 21(1):2274. PubMed ID: 34903209
[TBL] [Abstract][Full Text] [Related]
9. "It is not that I forget, it's just that I don't want other people to know": barriers to and strategies for adherence to antiretroviral therapy among HIV patients in Northern Vietnam.
Van Tam V; Pharris A; Thorson A; Alfven T; Larsson M
AIDS Care; 2011 Feb; 23(2):139-45. PubMed ID: 21259125
[TBL] [Abstract][Full Text] [Related]
10. Modality of Primary HIV Disclosure and Association with Mental Health, Stigma, and Antiretroviral Therapy Adherence in Tanzanian Youth Living with HIV.
Ramos JV; Mmbaga BT; Turner EL; Rugalabamu LL; Luhanga S; Cunningham CK; Dow DE
AIDS Patient Care STDS; 2018 Jan; 32(1):31-37. PubMed ID: 29323556
[TBL] [Abstract][Full Text] [Related]
11. Perceived Stigma and Fear of Unintended Disclosure are Barriers in Medication Adherence in Adolescents with Perinatal HIV in Botswana: A Qualitative Study.
Madiba S; Josiah U
Biomed Res Int; 2019; 2019():9623159. PubMed ID: 31886271
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with self-reported adherence to antiretroviral therapy in a Tanzanian setting.
Watt MH; Maman S; Golin CE; Earp JA; Eng E; Bangdiwala SI; Jacobson M
AIDS Care; 2010 Mar; 22(3):381-9. PubMed ID: 20390519
[TBL] [Abstract][Full Text] [Related]
13. Adherence to antiretroviral therapy and retention in care for adolescents living with HIV from 10 districts in Uganda.
Nabukeera-Barungi N; Elyanu P; Asire B; Katureebe C; Lukabwe I; Namusoke E; Musinguzi J; Atuyambe L; Tumwesigye N
BMC Infect Dis; 2015 Nov; 15():520. PubMed ID: 26573923
[TBL] [Abstract][Full Text] [Related]
14. "I want to stand on my own legs": A qualitative study of antiretroviral therapy adherence among HIV-positive women in Egypt.
Badahdah AM; Pedersen DE
AIDS Care; 2011 Jun; 23(6):700-4. PubMed ID: 21476148
[TBL] [Abstract][Full Text] [Related]
15. Understanding reasons for treatment interruption amongst patients on antiretroviral therapy--a qualitative study at the Lighthouse Clinic, Lilongwe, Malawi.
Tabatabai J; Namakhoma I; Tweya H; Phiri S; Schnitzler P; Neuhann F
Glob Health Action; 2014; 7():24795. PubMed ID: 25280736
[TBL] [Abstract][Full Text] [Related]
16. HIV-Positive Patients' Perceptions of Antiretroviral Therapy Adherence in Relation to Subjective Time: Imprinting, Domino Effects, and Future Shadowing.
Lessard D; Toupin I; Engler K; Lènàrt A; ; Lebouché B
J Int Assoc Provid AIDS Care; 2018; 17():2325958218759208. PubMed ID: 29473484
[TBL] [Abstract][Full Text] [Related]
17. A qualitative study of community home-based care and antiretroviral adherence in Swaziland.
Root R; Whiteside A
J Int AIDS Soc; 2013 Oct; 16():17978. PubMed ID: 24107652
[TBL] [Abstract][Full Text] [Related]
18. Influences on Adherence to Antiretroviral Therapy (ART) in Early-Stage HIV Disease: Qualitative Study from Uganda and South Africa.
Ware NC; Wyatt MA; Pisarski EE; Bwana BM; Orrell C; Asiimwe S; Amanyire G; Musinguzi N; Bangsberg DR; Haberer JE;
AIDS Behav; 2020 Sep; 24(9):2624-2636. PubMed ID: 32140877
[TBL] [Abstract][Full Text] [Related]
19. Understanding reasons for discontinued antiretroviral treatment among clients in test and treat: a qualitative study in Swaziland.
Shabalala FS; Vernooij E; Pell C; Simelane N; Masilela N; Spiegelman D; Chai B; Khan S; Reis R
J Int AIDS Soc; 2018 Jul; 21 Suppl 4(Suppl Suppl 4):e25120. PubMed ID: 30027651
[TBL] [Abstract][Full Text] [Related]
20. Social and economic barriers to adherence among patients at Livingstone General Hospital in Zambia.
Moomba K; Van Wyk B
Afr J Prim Health Care Fam Med; 2019 Apr; 11(1):e1-e6. PubMed ID: 31038336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
